 |
[ About Us | GPI Staff | Science Advisory Board ]
[ Human Rights: Legal Advisory Board | Board of Directors | Strategic Advisory Board | State Liaisons ]
About Us
Leading the global cause of stem cell research
The Genetics Policy Institute (GPI) is the leading nonprofit organization dedicated to establishing a positive legal framework to advance stem cell research. GPI maintains science and legal advisory boards comprised of leading stem cell researchers, disease experts, ethicists and legal experts and a dedicated full-time staff of policy experts that are available to educate the public and media on stem cell issues.
Hundreds of millions of people worldwide suffer from diseases, injuries and birth defects that could potentially be cured through stem cell treatments. These conditions include cancer, heart disease, ALS, spinal cord injury, osteoarthritis, diabetes, blindness, AIDS, brain injury, severe burns, autoimmune disease, kidney, liver and lung disease, and many others. In fact, any disease that involves the degeneration or death of some type of specialized cell could possibly benefit from stem cell transplants.
Funding restrictions in the United States and proposals to ban and criminalize aspects of the research have created major roadblocks to the advancement of potentially lifesaving treatments. GPI leads the charge to defend the rights of patients and for the preservation of scientific freedom against well-funded opposition groups.
GPI is the catalyst of the "Pro-Cures Movement," a global coalition of pro-research stakeholders. Through GPI's meetings, publications, press relations, web site, speaker's bureau and teaching initiatives, GPI educates the public, media and key decision-makers on critical issues. We analyze global law and regulations relating to all aspects of regenerative medicine with an eye to removing bottlenecks, while maintaining rigorous ethical oversight.
The Genetics Policy Institute was the principal global organizer of a coalition that successfully defended vital stem cell research against an anti-research United Nations treaty, which sought to impose a worldwide ban on somatic cell nuclear transfer. GPI convened the world's preeminent scientists for a conference at the UN to educate the delegations about stem cell issues. We created a series of annual stem cell summit events partnering with prestigious academic centers including Baylor College of Medicine, Stanford University and the Harvard Stem Cell Institute. In September 2008, we will present the World Stem Cell Summit in Madison, Wisconsin hosted by the University of Wisconsin Stem Cell & Regenerative Medicine Center and WiCell Research Institute.
GPI's special educational project is the Student Society for Stem Cell Research (SSSCR), which started with a single university student in 2003 and has grown into a network of more than 2,500 students in 15 countries, 35 states and 30 chapters at colleges and universities. Each chapter of SSSCR creates educational programming on the promise of stem cell research.
GPI Staff
Science Advisory Board
GPI has recruited the leading stem cell scientists, researchers and physicians in the field of biomedical research to serve on our Scientific Advisory Board.
Genevieve
Ames, Ph.D.
University of California-Berkeley, School of Public Health
Berkeley, California
Juan
Dominguez Bendala, MSC, PhD.
Diabetes Research Institute
Miller School of Medicine
University of Miami
Miami, Florida
Elizabeth
Blackburn, Ph.D.
University of California-San Francisco
Former president, American Society of Cell Biology
Former member of the President's Council on Bioethics
San Francisco, California
William
(Bill) Brinkley, PhD.
Senior Vice President for Graduate Sciences
Dean of the Graduate School of Biomedical Sciences
Baylor College of Medicine
Houston, Texas
Torrey
Brown, M.D.
Intralytix, Inc.
Baltimore, Maryland
Keith
H.S. Campbell, BSc, DPhil
Professor of Animal Development
University of Nottingham
United Kingdom
Gabriela Gebrin Cezar, D.V.M., Ph.D.
Assistant Professor
University of Wisconsin-Madison
Madison, Wisconsin
Jose
B. Cibelli, D.V.M., PhD.
Cellular Reprogramming Laboratory
Michigan State University
Lansing, Michigan
W.
Dalton Dietrich, Ph.D.
Scientific Director, The Miami Project to Cure Paralysis
Miller School of Medicine
University of Miami
Miami, Florida
Helena Edlund, Ph.D.
Umea University, Sweden
Fred
H. Gage, Ph.D.
Laboratory of Genetics
Salk Institute for Biological Studies
La Jolla, California
John
Gearhart, MSc, Ph.D.
Johns Hopkins University School of Medicine & Bloomberg School of Public Health
Baltimore, Maryland
Lawrence
Goldstein, Ph.D.
Professor of Cellular and Molecular Medicine
University of California, San Diego
San Diego, California
Prof. Raphael Gorodetsky
Head, Biotechnology and Radiobiology Labs
Sharett Institute of Oncology
Hadassah - Hebrew University Medical Center
Jerusalem, Israel
Judith Grossberg, M.D.
VCU School of Medicine
Richmond, Virginia
Luca
Inverardi, M.D
Diabetes Research Institute
Miller School of Medicine
University of Miami
Miami, Florida
Rudolf
Jaenisch, M.D.
Member, Whitehead Institute
Professor of Biology
Massachusetts Institute of Technology
Cambridge, Massachusetts
Stephen
E. Levick, M.D.
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
|
Alan S. Levine, PhD.
Chief Scientific Officer
CORD:USE
Cord Stem Cell Bank
Orlando, Florida
T.C.
Anand Kumar, D.Sc., FASc, FAMS
Chairman
Hope Infertility Clinic and Research Foundation
Bangalore, India
Jeanne
Loring, PhD.
Adjunct Associate Professor
Burnham Institute for Medical Research
La Jolla, California
Joe Massey, M.D.
Reproductive Biology Associates
Atlanta, Georgia
John W. McDonald, MD., PhD.
International Center for Spinal Cord Injury Kennedy Krieger Institute
Baltimore, Maryland
Douglas
Melton, Ph.D.
Scientific Director
Harvard Stem Cell Institute
Harvard University
Cambridge, Massachusetts
Roger Pederson, Ph.D.
Professor of Regenerative Medicine
University of Cambridge
United Kingdom
Mark Noble, PhD.
Department of Biomedical Genetics
University of Rochester Medical Center
Rochester, New York
Camillo
Ricordi, M.D.
Scientific Director
Diabetes Research Institute
Miller School of Medicine
University of Miami
Miami, Florida
Evan Snyder, M.D., Ph.D.
Program Director
Stem Cells and Regeneration
Burnham Institute for Medical Research
La Jolla, California
Sally Temple, PhD.
New York Neural Stem Cell Institute
Albany, New York
Alan Trounson, Ph.D.
President
California Institute for Regenerative Medicine
San Francisco, California
Robert D. Wells, PhD.
Director of the Center of Genome Research
Institute of Biosciences and Technology
Texas A&M University
Houston, Texas
Ian Wilmut, Ph.D.
Director, Centre for Regenerative Medicine
The Queen's Medical Research Institute
University of Edinburgh
Edinburgh, United Kingdom
Wise
Young, PhD. MD.
Professor and Chair
W.M. Kleck Ceneter for Collaborative Neuroscience
Rutgers, The State University of New Jersey
New Brunswick, New Jersey
Mark A. Zern, M.D.
Director, Transplant Research Institute
University of California-Davis
Sacramento, California
Len
Zon, M.D.
Director Stem Cell Research Program
Past President, International Society for Stem Cell Research
Children's Hospital Boston
Harvard University Medical School
Boston, Massachusetts
Thomas P. Zwaka, M.D. Ph.D.
Center for Cell and Gene Therapy & Department of Molecular and Cellular Biology
Baylor College of Medicine
Houston, Texas
|
Human Rights: Legal Advisory Board
|
Chris Bell, J.D.
former member U.S. House of Representatives
Houston, Texas
Susan L. Crockin, J.D.
The Crockin Law & Policy Group, LLC.
Newton, Massachusetts
James Lawford Davies
Clifford Chance
London, United Kingdom
Janet L. Dolgin, PhD, J.D.
Jack and Freda Dicker Distinguished
Professor of Health Care Law
Hofstra University School of Law
Hempstead, New York
Mark S. Ellinger, PhD., J.D.
Principal, Fish & Richardson, P.C.
Minneapolis, Minnesota
Richard Falk, Ph.D.
Milbank Professor of International Law Emeritus
Princeton University
Louis M. Guenin, J.D.
Lecturer on Ethics in Science
Department of Microbiology and Molecular Genetics
Harvard Medical School
Boston, Massachusetts
James E. Grossberg, J.D.
Levine Sullivan Koch & Schulz, LLP.
Washington, D.C.
Alan L. Jakimo, M.B.A., JD.
Partner
Sidley Austin, LLP
New York, New York
Nihal Jayawickrama, Ph.D.
formerly Sallows Professor of Human Rights at the University of Saskatchewan
London, United Kingdom
|
Bruce W. Jenett, J.D.
Co-Leader, Life Sciences Practice
Heller Ehrman LLP
Palo Alto, California
Prof. Russell Korobkin
UCLA School of Law
Los Angeles, California
Ana Lita, PhD.
Director
IHEU-Appignani Center for Bioethics at the United Nations
New York, New York
S. Peter Ludwig, J.D.
Partner, Darby & Darby
New York, New York
David C. Magnus, PhD.
Stanford Center for Biomedical Ethics
Stanford University
Palo Alto, California
Prof. Fabio Marazzi
managing director M+Biolaw
Milan, Italy
Jonathan D. Moreno, PhD.
Director, Center for Biomedical Ethics
University of Virginia
Charlottesville, Virginia
John A. Robertson, J.D.
Vinson & Elkins Chair in Law
University of Texas Law School
Austin, Texas
Jeffrey S. Ross, J.D.
Partner, Pillsbury Winthrop Shaw Pittman LLP
San Francisco, California
Christopher Weeramantry
World Court Judge (retired) - Sri Lanka
Emeritus Professor of Law at Monash University
Laurie Zoloth, PhD
Director, Bioethics, Center for Genetics Medicine
Northwestern University
Evanston, Illinois
|
Board of Directors
|
William R. Brinkley
Houston, Texas
G. Steven Burrill
San Francisco, CA
Timothy Choate
Alexandria, Virginia
Ralph Dittman
Houston, Texas
|
Richard S. Grossberg
Richmond, Virginia
Danny Heumann
Ann Arbor, Michigan
S. Peter Ludwig
New York, New York
Bernard Siegel
Wellington, Florida
|
Strategic Advisory Board
|
Sabrina Cohen
Founder and Executive Director
Sabrina Cohen Foundation for Stem Cell Research
Miami Beach, Florida
James Canton, PhD.
CEO, Institute for Global Futures
San Francisco, California
Brooke Ellison
BrookePAC
Stony Brook, New York
Fremont, California
|
Don C. Reed
Californians for Cures
Fremont, California
Ronald G. Stone
Miami, Florida
Monk Terry
Miami, Florida
Andrew Tobias
New York, New York
|
GPI State Liaisons
Carol Horvitz, JD, MPH
Massachusetts Liaison
|
